CANSLIM Stock Screener – 2026-09-26 (161 Stocks)

The scan returned 161 qualifying names, with leadership heavily clustered in three software and chip categories. Semiconductors accounted for 25 stocks, Software – Infrastructure also contributed 25, and Software – Application added 21. That means roughly 44 percent of the entire list sits in just three related technology groups, a clear sign that the current CAN SLIM stock screener output is tilted toward a narrow band of the market.

Ten names appeared on two or more of the screens, which is the strongest form of cross-confirmation available in this data. That group includes AMD, ANET, NET, NTAP, PLTR, SNOW, AVT, DDOG, DELL, and ECO. Turnover at the edges was active: 24 names entered the list versus the prior session, while 14 dropped out, suggesting rotation rather than a wholesale shift in leadership among CANSLIM stocks.

Among the names selected by all three screens, two distinct patterns stand out. AMD and NET are both in Climax run formations with immature bases, each showing 0.0 percent depth and only 0.2 weeks of formation, with pivots at $629.26 and $358.82 respectively. ANET and NTAP, by contrast, show VCP patterns with mature bases: ANET has 12.7 percent depth over 6.2 weeks with a pivot of $210.5, while NTAP shows the same 12.7 percent depth over 5.8 weeks with a pivot of $207.08. PLTR and SNOW are both in Rising wedge formations with immature bases; PLTR carries a notably deep 48.2 percent base over 44.8 weeks with a pivot of $207.18, whereas SNOW shows 9.4 percent depth over 3.0 weeks with a pivot of $356.47.

For educational purposes only — not investment advice.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.